One report, for instance, has commented that intensity of immunohistochemical IL-13Rα1 staining tends to be stronger in psoriasis lesions that are larger in size [31], which potentially, may reflect differential activation of IL-13-sensitive pathways across stages of plaque development. This evidence concerns the gene IL13 and psoriasis.